Assessing plasminogen activation potential with global fibrinolytic assays

QR Code

Assessing plasminogen activation potential with global fibrinolytic assays

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tetsumei Urano, Yuko Suzuki
Format:	article
Langue:	EN
Publié:	Wiley 2020
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/35f81773c6bc4a598b1fa99a88aa43c0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

IL-15 as a potential target in leukemia
par: Xiong Y, et autres
Publié: (2015)

Profile of elotuzumab and its potential in the treatment of multiple myeloma
par: Liu YC, et autres
Publié: (2014)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
par: Gupta VA, et autres
Publié: (2013)

Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia
par: O&#39;Brien S, et autres
Publié: (2012)

Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia
par: Thomas X
Publié: (2014)

Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application
par: Li-Min Lin, et autres
Publié: (2021)

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
par: Illidge T, et autres
Publié: (2012)

ASSESSMENT OF THE NUTRITIONAL STATUS, BONE MINERALIZATION AND ANTHROPOMETRICS OF CHILDREN WITH THALASSEMIA MAJOR
par: Serap Cevher Bulğurcu, et autres
Publié: (2021)

Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism
par: Wardah Aslam, et autres
Publié: (2021)

Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study
par: Myrthe M. van der Bruggen, et autres
Publié: (2021)

THE EVALUATION OF HEALTHY CHILDREN WITH INCIDENTAL PROLONGATION OF PROTHROMBIN OR ACTIVATED PARTIAL THROMBOPLASTIN TESTS
par: Gökcen MERAL, et autres
Publié: (2021)

Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
par: Shanshan Zhang, et autres
Publié: (2021)

Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment
par: Pujals A, et autres
Publié: (2015)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
par: Nair KS, et autres
Publié: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
par: Jennifer Gill, et autres
Publié: (2020)

All bleeding matters … but the details may not
par: Sarah H. O’Brien
Publié: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
par: Eko A. Pangarsa, et autres
Publié: (2021)

PP Transcon 2020 Abstracts Compilation
Publié: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
par: Rasika D Setia, et autres
Publié: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
par: Anand Deshpande, et autres
Publié: (2021)

Oration - Dr Sanmukh Joshi
Publié: (2021)

OP Transcon 2020 Abstracts Compilation
Publié: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publié: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
par: Vijeta Bajpai, et autres
Publié: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
par: Shoumariyeh K, et autres
Publié: (2014)

MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
par: Moormann AM, et autres
Publié: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
par: Sawey K, et autres
Publié: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
par: Smolewski P, et autres
Publié: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
par: Samuel sarmiento Doncel, et autres
Publié: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
par: Brian Eyden, et autres
Publié: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
par: Ming Hou
Publié: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
par: Hooriyeh Shapoorian, et autres
Publié: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
par: Meletios A. Dimopoulos, et autres
Publié: (2021)